Back
Spyre Therapeutics Quote, Financials, Valuation and Earnings
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Sell
40
SYRE
Spyre Therapeutics
Last Price:
26.84
Seasonality Move:
-1.09%
7 Day Trial
ALL ACCESS PASS
$
7
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Spyre Therapeutics Price Quote
$26.84
-0.66 (-2.4%)
(Updated: November 21, 2024 at 9:40 AM ET)
Spyre Therapeutics Key Stats
Sell
40
Spyre Therapeutics (SYRE)
is a Sell
Day range:
$26.81 - $28.48
52-week range:
$8.75 - $47.97
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
985.10
P/B ratio:
8.59%
Volume:
1.2M
Avg. volume:
576.7K
1-year change:
161.9%
Market cap:
$1.5B
Revenue:
$886K
EPS:
$-5.17
How Much Does Spyre Therapeutics Make?
Data Unavailable
Is Spyre Therapeutics Growing As A Company?
Data Unavailable
Spyre Therapeutics Stock Price Performance
-
Did Spyre Therapeutics Stock Go Up Last Month?
Spyre Therapeutics share price went down by -16.06% last month -
Did SYRE's Share Price Rise Over The Last Year?
SYRE share price rose by 161.9% over the past 1 year
What Is Spyre Therapeutics 52-Week High & Low?
-
What Is Spyre Therapeutics’s 52-Week High Share Price?
Spyre Therapeutics has traded as high as $47.97 over the past 52 weeks -
What Is Spyre Therapeutics’s 52-Week Low Share Price?
Spyre Therapeutics has traded as low as $8.75 over the past 52 weeks
Spyre Therapeutics Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Spyre Therapeutics?
-
How Much Debt Does Spyre Therapeutics Have?
Total long term debt quarterly is $0 -
How Much Cash Does Spyre Therapeutics Have?
Cash and short term investments quarterly total is $414.2M -
What Is Spyre Therapeutics’s Book Value Per Share?
Book value per share is 3.34
Is Spyre Therapeutics Cash Flow Positive?
-
What Is SYRE Cash Flow From Operations?
Cash flow from operations (TTM) is -$151.2M -
What Is Spyre Therapeutics’s Cash Flow From Financing?
Cash flow from financing (TTM) is $348.9M -
What Is Spyre Therapeutics’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$218M
Spyre Therapeutics Return On Invested Capital
Data Unavailable
Spyre Therapeutics Earnings Date & Stock Price
-
What Is Spyre Therapeutics's Stock Price Today?
A single share of SYRE can be purchased today for 27.50 -
What Is Spyre Therapeutics’s Stock Symbol?
Spyre Therapeutics trades on the nasdaq under the ticker symbol: SYRE -
When Is Spyre Therapeutics’s Next Earnings Date?
The next quarterly earnings date for Spyre Therapeutics is scheduled on February 28, 2025 -
When Is SYRE's next ex-dividend date?
Spyre Therapeutics's next ex-dividend date is November 21, 2024 -
How To Buy Spyre Therapeutics Stock?
You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Spyre Therapeutics Competitors
-
Who Are Spyre Therapeutics's Competitors?
Below is a list of companies who compete with Spyre Therapeutics or are related in some way:
Spyre Therapeutics Dividend Yield
-
What Is SYRE Dividend Yield?
Spyre Therapeutics’s dividend yield currently is 0% -
What Is Spyre Therapeutics’s Payout Ratio?
Spyre Therapeutics’s payout ratio is 0% -
When Did Spyre Therapeutics Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Spyre Therapeutics’s Dividend Per Share?
Spyre Therapeutics pays a dividend of $0.00 per share
Spyre Therapeutics Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | -57.77% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 10 |
|---|---|
| Hold Recommendations: | 0 |
| Sell Recommendations: | 0 |
| Price Target: | 58.63 |
| Upside from Last Price: | 113.18% |